Related Experiment Video
Updated: Sep 2, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Mitral valve replacement for lupus valvulitis
Zeitschrift Fur Rheumatologie
|November 1, 1986
Insights
This study reports the longest survival after mitral valve replacement for lupus valvulitis. A 47-year-old patient with lupus valvulitis survived for over four years post-prosthesis implantation.
Area of Science:
- Cardiology
- Rheumatology
- Medical Case Study
Background:
- Lupus valvulitis is a rare cardiac manifestation of systemic lupus erythematosus.
- Mitral insufficiency secondary to lupus valvulitis necessitates surgical intervention.
- Prosthetic valve replacement is a treatment option for severe mitral regurgitation.
Observation:
- A 47-year-old patient with a 6.5-year history of lupus valvulitis presented with mitral insufficiency.
- The patient underwent successful mitral valve replacement with a Starr-Edwards prosthesis four years prior to this report.
- This represents a prolonged survival period for a patient with this condition.
Findings:
- The patient achieved the longest reported survival duration after mitral valve replacement for lupus valvulitis.
- The Starr-Edwards prosthesis demonstrated durability and efficacy in this specific clinical context.
- Successful management of lupus valvulitis-associated cardiac dysfunction is achievable.
Implications:
- This case highlights the potential for long-term survival in patients with lupus valvulitis undergoing valve replacement.
- It underscores the importance of multidisciplinary management for autoimmune-related cardiac conditions.
- Further research into long-term outcomes and optimal prosthetic choices for lupus valvulitis patients is warranted.
Abstract:
This paper describes a 47-years old patient with the history of lupus valvulitis for six and a half years, who had implantation of a Starr-Edwards prosthesis for a mitral insufficiency four years ago. This case represents the longest survival reported so far after mitral valve replacement for lupus valvulitis.
Related Concept Videos
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...